The prevalence and occurrence of sleep apnea syndrome in head and neck tumor patients: the efficacy of pre- and posttreatment.
Not Applicable
- Conditions
- Head and neck tumor and sleep apnea syndrome.
- Registration Number
- JPRN-UMIN000032070
- Lead Sponsor
- Juntendo University
- Brief Summary
A total of 32 patients were underwent pre-treatment sleep tests. The prevalence of OSA was 81.3% before treatment. The mean AHI was 20.8 events/hr. Next, 21 patients were performed a sleep test both before and after treatment. Overall, the AHI was no significant difference, from 14.5 to 14.9 after treatment (P=0.147). The MRI parameters showed that the retroglossal pharyngeal area increased significantly after treatment (P=0.007).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who die during the study period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This is prospective study for 12 months-follow-up. Nasopharyngeal scope, blood tests, rhinometry and polysomnography are planned.
- Secondary Outcome Measures
Name Time Method